KRAS mutation and microsatellite instability in endometrial adenocarcinomas showing MELF-type myometrial invasion
Authors:
- 30 June 2010
- journal article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 63 (7) , 604-608
Abstract
Background: Some uterine endometrioid adenocarcinomas exhibit a distinctive morphological phenotype characterised by the formation of microcystic, elongated and fragmented (MELF) glands. Immunohistochemical studies have suggested that MELF-type changes represent an epithelial–mesenchymal transition which has been associated with KRAS activation in various tumours. Aims: To investigate the molecular characteristics of endometrial tumours showing MELF, with particular reference to the frequencies of KRAS and BRAF mutations and of microsatellite instability (MSI). Methods: MSI, and KRAS and BRAF mutation status, were assessed in 33 low-grade endometrial adenocarcinomas showing MELF features and the results compared with 33 control cases exhibiting a ‘conventional’ pattern of myometrial invasion. Standard histological parameters were also reviewed. Results: Tumours with a MELF pattern of myometrial invasion showed more frequent vascular invasion and focal mucinous differentiation. KRAS mutations were more frequent in MELF positive than MELF negative tumours (45% vs 30%), but this difference was not statistically significant. BRAF mutations were not identified in any of the cases. MSI was identified in 20% of cases overall but did not correlate with the MELF phenotype. Conclusions: Mutations in KRAS and BRAF genes are not directly implicated in the development of a MELF pattern of invasion in endometrial carcinoma. However, RAS-associated signalling pathways could be activated through other genetic or epigenetic mechanisms. The characterisation of such alterations may become increasingly important as novel therapies are developed that target mediators involved in tumour invasion.Keywords
This publication has 53 references indexed in Scilit:
- Endometrial Hyperplasia and Carcinoma2008
- Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progressionJournal of Cellular Physiology, 2007
- RASSF1A hypermethylation and its inverse correlation with BRAF and/or KRAS mutations in MSI‐associated endometrial carcinomaInternational Journal of Cancer, 2006
- Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironmentCellular and Molecular Life Sciences, 2006
- Low frequency of BRAF and CDKN2A mutations in endometrial cancerInternational Journal of Cancer, 2005
- Frequent nuclear ?-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiationThe Journal of Pathology, 2001
- K-ras mutations in endometrial carcinomas with microsatellite instabilityThe Journal of Pathology, 2000
- The frequency of p53, k-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinomaCancer, 2000
- Differences in patterns ofTP53 andKRAS2 mutations in a large series of endometrial carcinomas with or without microsatellite instabilityCancer, 1999
- Microsatellite Instability and Somatic Mutations in Endometrial CarcinomasGynecologic Oncology, 1998